Developing high-value, global products for patients with significant unmet medical needs in niche indications
Employees: 51-200
Founded date: 2004
Investors 2
Date | Name | Website |
- | Sofinnova ... | sofinnovap... |
- | Industrifo... | industrifo... |
Mentions in press and media 12
Date | Title | Description | Source |
18.04.2024 | Calliditas Therapeutics Presents Additional Data Analyses fr... | Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon... | news.cisio... |
06.11.2023 | Calliditas Presents Additional Data Analyses from the NefIgA... | Calliditas Presents Additional Data Analyses from the NefIgArd Phase 3 trial at the American Society... | news.cisio... |
28.04.2023 | Notice of annual general meeting of Calliditas Therapeutics ... | Notice of annual general meeting of Calliditas Therapeutics AB (publ) Fri, Apr 28, 2023 08:30 CET Re... | news.cisio... |
16.12.2021 | Milestone for Calliditas as FDA grants accelerated approval ... | Our portfolio company Calliditas Therapeutics reached a major milstone yesterday with its accelerate... | industrifo... |
16.12.2021 | Everest Medicines announces FDA grants our Partner Callidita... | TARPEYO (budesonide) delayed release capsules is the first and only treatment indicated to reduce pr... | en.prnasia... |
19.07.2021 | Calliditas Therapeutics : secures $75 million term loan faci... | Calliditas secures $75 million term loan facility Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq S... | marketscre... |
15.07.2021 | Calliditas secures $75 million term loan facility | Calliditas secures $75 million term loan facility Thu, Jul 15, 2021 08:20 CET Calliditas Therapeutic... | news.cisio... |
15.07.2021 | Calliditas Therapeutics : secures $75 million term loan faci... | Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today an... | marketscre... |
15.07.2021 | Calliditas Secures $75 Million Term Loan Facility | Calliditas Therapeutics AB announced that the company has signed a loan agreement of up to the Euro ... | marketscre... |
27.04.2021 | CALLIDITAS THERAPEUTICS AB (PUBL) Calliditas Therapeutics :... | Corporate Governance Report Introduction Calliditas Therapeutics AB (publ), "Calliditas" i... | marketscre... |
Show more